Showing results (261-270 of 292) with videos related to
Sort By:
Pageof 30
Cancer Genetics|September 22, 2021
Novel genomic signature predictive of response to immune checkpoint blockade: A pan-cancer analysis from project Genomics Evidence Neo-plasia Information Exchange (GENIE)Nishwant Swami, William L Hwang, Jimmy A Guo, et al.Head & Neck|March 9, 2021
Intensity-modulated radiation therapy for nasal cavity and paranasal sinus tumors: Experience from a single instituteSarbani Ghosh Laskar, Prathamesh Pai, Shwetabh Sinha, et al.South Asian Journal of Cancer|December 22, 2025
Patterns of Failure in Head and Neck Carcinoma of Unknown Primary: Insights from a Tobacco-Associated Cancer CohortSarbani Ghosh Laskar, Jifmi Jose Manjali, Ashwini Budrukkar, et al.European Urology Oncology|April 12, 2026
Extended Follow-up from the Stereotactic Body Radiotherapy for High-risk Localized Carcinoma of the Prostate (SHARP) Consortium: Updated Analysis of 440 PatientsLuca F Valle, Tahmineh Romero-Kalbasi, Tommy Jiang, et al.Immunology and Cell Biology|September 28, 2021
Comprehensive immune cell profiling depicts an early immune response associated with severe coronavirus disease 2019 in cancer patientsPrashant R Tembhare, Harshini Sriram, Gaurav Chatterjee, et al.International Journal of Clinical Practice|June 10, 2022
Genomic Analysis of AZD1222 (ChAdOx1) Vaccine Breakthrough Infections in the City of MumbaiArusha Shetty, Gaurav Chatterjee, Sweta Rajpal, et al.European Urology|May 18, 2017
A Prostate Cancer "Nimbosus": Genomic Instability and SChLAP1 Dysregulation Underpin Aggression of Intraductal and Cribriform SubpathologiesMelvin L K Chua, Winnie Lo, Melania Pintilie, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2017
Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority TrialVanita Noronha, Amit Joshi, Vijay Maruti Patil, et al.JNCI Cancer Spectrum|August 1, 2023
Use of the Decipher genomic classifier among men with prostate cancer in the United StatesNicholas G Zaorsky, James A Proudfoot, Angela Y Jia, et al.European Urology|December 9, 2020
A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate CancerNeil K Jairath, Alan Dal Pra, Randy Vince, et al.Pageof 30